Hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a retrospective study of 21 patients from SFGM-TC centers.
No abstract text is available yet for this article.
Full text links
We have located links that may give you full text access.
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app